Breaking News
Get 40% Off 0
⚠ Earnings Alert! Which stocks are poised to surge?
See the stocks on our ProPicks radar. These strategies gained 19.7% year-to-date.
Unlock full list
Close

Astellas Pharma Inc. (4503)

Create Alert
New!
Create Alert
Website
  • As an alert notification
  • To use this feature, make sure you are signed-in to your account
Mobile App
  • To use this feature, make sure you are signed-in to your account
  • Make sure you are signed-in with the same user profile

Condition

Frequency

Once
%

Frequency

Frequency

Delivery Method

Status

Add to/Remove from a Portfolio Add to Watchlist
Add to Watchlist
Add Position

Position added successfully to:

Please name your holdings portfolio
 
1,486.5 +21.0    +1.43%
03:30:00 - Delayed Data. Currency in JPY ( Disclaimer )
  • Volume: 3,723,700
  • Bid/Ask: 1,492.0 / 1,492.5
  • Day's Range: 1,467.5 - 1,494.0
Type:  Equity
Market:  Japan
ISIN:  JP3942400007 
Astellas Pharma Inc. 1,486.5 +21.0 +1.43%

4503 Income Statement & Profits

 
Assess the Astellas Pharma Inc. income statement, view the company's financial performance across their assets and liabilities. Select to view either quarterly or annual data.
AnnualQuarterly
InvestingPro Advanced Income Statement
Period Ending: 2023
31/12
2023
30/09
2023
30/06
2023
31/03
Total Revenue 421932 392148 374990 354254
Revenue 421932 392148 374990 354254
Other Revenue, Total - - - -
Cost of Revenue, Total 75897 74412 68947 62280
Gross Profit 346035 317736 306043 291974
Total Operating Expenses 403064 391226 329935 302302
Selling/General/Admin. Expenses, Total 199499 179280 168182 159295
Research & Development 74387 77355 64592 70076
Depreciation / Amortization 46984 38969 23244 23017
Interest Expense (Income) - Net Operating -2830 -2269 -2720 -413
Unusual Expense (Income) - - - -
Other Operating Expenses, Total 9127 23479 7690 -11953
Operating Income 18868 922 45055 51952
Interest Income (Expense), Net Non-Operating - - - -
Gain (Loss) on Sale of Assets 318 9363 54 -5003
Other, Net 1237 -17909 -1849 104832
Net Income Before Taxes 17313 9468 46850 -47877
Provision for Income Taxes 2800 6787 13721 -1752
Net Income After Taxes 14513 2681 33129 -46125
Minority Interest - - - -
Equity In Affiliates - - - -
U.S GAAP Adjustment - - - -
Net Income Before Extraordinary Items 14513 2681 33129 -46125
Total Extraordinary Items - - - -
Net Income 14513 2681 33129 -46125
Total Adjustments to Net Income - - - -
Income Available to Common Excluding Extraordinary Items 14513 2681 33129 -46125
Dilution Adjustment 3.27 2.23 -1.05 1.71
Diluted Net Income 14509.73 2678.77 33130.05 -46126.71
Diluted Weighted Average Shares 1800.22 1800.18 1798.59 1809.69
Diluted EPS Excluding Extraordinary Items 8.06 1.49 18.42 -25.49
DPS - Common Stock Primary Issue 35 35 - 30
Diluted Normalized EPS 5.9 0.036 16.26 16.27
* In Millions of JPY (except for per share items)
InvestingPro
Go to Dashboard InvestingPro

Unlock access to over 1000 metrics with InvestingPro

View advanced insights on the income statement, including growth rates and metrics that provide an in-depth view of the company's historical and forecasted financial performance.

 
Comment Guidelines

We encourage you to use comments to engage with users, share your perspective and ask questions of authors and each other. However, in order to maintain the high level of discourse we’ve all come to value and expect, please keep the following criteria in mind: 

  • Enrich the conversation
  • Stay focused and on track. Only post material that’s relevant to the topic being discussed.
  • Be respectful. Even negative opinions can be framed positively and diplomatically.
  •  Use standard writing style. Include punctuation and upper and lower cases.
  • NOTE: Spam and/or promotional messages and links within a comment will be removed
  • Avoid profanity, slander or personal attacks directed at an author or another user.
  • Don’t Monopolize the Conversation. We appreciate passion and conviction, but we also believe strongly in giving everyone a chance to air their thoughts. Therefore, in addition to civil interaction, we expect commenters to offer their opinions succinctly and thoughtfully, but not so repeatedly that others are annoyed or offended. If we receive complaints about individuals who take over a thread or forum, we reserve the right to ban them from the site, without recourse.
  • Only English comments will be allowed.

Perpetrators of spam or abuse will be deleted from the site and prohibited from future registration at Investing.com’s discretion.

4503 Price Commentary

Write your thoughts about Astellas Pharma Inc.
 
Are you sure you want to delete this chart?
 
Post
Post also to:
 
Replace the attached chart with a new chart ?
1000
Your ability to comment is currently suspended due to negative user reports. Your status will be reviewed by our moderators.
Please wait a minute before you try to comment again.
Thanks for your comment. Please note that all comments are pending until approved by our moderators. It may therefore take some time before it appears on our website.
 
Are you sure you want to delete this chart?
 
Post
 
Replace the attached chart with a new chart ?
1000
Your ability to comment is currently suspended due to negative user reports. Your status will be reviewed by our moderators.
Please wait a minute before you try to comment again.
Add Chart to Comment
Confirm Block

Are you sure you want to block %USER_NAME%?

By doing so, you and %USER_NAME% will not be able to see any of each other's Investing.com's posts.

%USER_NAME% was successfully added to your Block List

Since you’ve just unblocked this person, you must wait 48 hours before renewing the block.

Report this comment

I feel that this comment is:

Comment flagged

Thank You!

Your report has been sent to our moderators for review
Continue with Google
or
Sign up with Email